Abstract Oocyte cryopreservation represents an important tool for assisted reproductive technology. It offers the opportunity to preserve fertility in women at risk of loss of the ovarian function for various pathologies. It also represents a treatment alternative for couples that cannot benefit from embryo cryopreservation because of moral, religious, or legal constrains. On the other hand, in vitro oocyte maturation has a range of applications. It can be applied in patients with a contraindication to ovarian stimulation to prevent ovarian hyperstimulation syndrome or to eliminate the risk of stimulation of hormone-sensitive tumours in cancer patients. However, while mature oocyte cryopreservation has found widespread application and oocyte in vitro maturation has a place for the treatment of specific clinical conditions, data on the efficiency of freezing of immature or in vitro matured oocytes are poorer. In this review we will focus on the combination of oocyte in vitro maturation with oocyte cryopreservation with particular emphasis on the biological implications of the cryopreservation of immature or in vitro matured oocytes. The two cryopreservation approaches, slow freezing and vitrification, will be discussed in relation to possible cryodamage occurring to subcellular structures of the oocyte and the functional interaction between oocyte and cumulus cells.
Introduction
Oocyte cryopreservation can significantly contribute to advances in infertility treatment and reproductive biology. From a clinical perspective, several applications can benefit from the development of an efficient oocyte cryopreservation program. It offers the opportunity to preserve fertility in women who want to postpone childbearing or at risk of loss of ovarian function. For example, this approach makes possible the preservation of fertility in patients with pathologies or dysfunctions affecting the reproductive system, such as premature ovarian failure (as in the case of several genetic disorders), and in patients who need gonadotoxic therapies. Moreover, cryopreservation of the female gamete could simplify oocyte donation programs and it is an important option for infertile couples who cannot benefit from embryo cryopreservation because of moral, religious, or legal constrains [1] .
So far, oocyte cryopreservation has been implemented for the storage of mature oocytes. However, many studies have been performed to improve the efficiency of oocyte cryopreservation techniques, focusing mostly on mature oocytes. Less is known about the efficiency and the consequences of cryopreservation on immature and in vitro matured oocytes. The combination of oocyte cryopreservation with in vitro maturation (IVM) represents an emerging concept. In current standard IVF protocols, women are treated with large doses of hormones that can have significant side effects. In the IVM approach, immature oocytes are retrieved from ovaries of untreated women, or following mild gonadotropin priming, and matured in vitro. IVM has a range of applications [2] . It can prevent ovarian hyperstimulation syndrome (OHSS), resolving cases in which the combined use of GnRH antagonist to suppress endogenous gonadotropin release and GnRH agonist to trigger final maturation is not sufficient to completely avoid the risk of development of the syndrome [3, 4] .
It can also be applied in patients with a contraindication to ovarian stimulation eliminating the risk of stimulation of hormone-sensitive tumours, such as breast cancer, especially in countries where the use of aromatase inhibitors is not allowed for IVF treatment [2] . In particular, IVM represents an important tool when gonadotoxic therapies cannot be delayed and there is not enough time to undergo ovarian stimulation [2] . Therefore, in recent years IVM treatment combined with oocyte cryopreservation has gained increasing interest. The aim of this review is to discuss the different cryopreservation approaches for the storage of immature and in vitro matured oocytes. Emphasis will be given to the biological implications of cryopreservation and IVM in regard to the physiology and structure of oocytes at different developmental stages.
Techniques for oocyte cryopreservation
The freezing of aqueous solutions causes a series of phenomena that may affect cell viability, such as formation of intracellular ice, osmotic stress, pH changes and alterations in solute concentration. Oocyte cryopreservation entails specific problems due to the large size, high water content and low membrane permeability of this cell. During freezing and thawing, the interaction of these factors may give raise to the formation of intracellular ice crystals causing extensive ultrastructural damage. Ice crystal formation can be avoided by removing most of water from the cytoplasm. This can be achieved by exposing the oocyte to cryoprotective agents (CPAs) to generate an osmotic gradient inducing oocyte dehydration. Moreover, cryoprotectants interact with water in such a way that the freezing point of the solution is lowered.
Common characteristics shared by CPAs are high water solubility and toxicity directly proportional to their concentration and temperature of use. CPAs are classified in permeating (dimethylsulfoxide, DMSO; ethylene glycol, EG; 1,2-propanediol, PrOH) and non-permeating (sucrose, trehalose) according to their capacity to penetrate cells. DMSO is a low molecular weight substance included in different protocols developed over several decades. EG is widely adopted as a constituent of vitrification solution for its relatively low toxicity [5] . PrOH has been used to cryopreserve cleavage stage embryos and blastocysts both in the human and animals. All these permeating agents may be used in mixture, especially in vitrification protocols, including also non-permeating CPAs [6] [7] [8] .
The major non-permeating agent routinely used in human oocyte cryopreservation is sucrose. Its presence in cryopreservation solutions involves several advantages during dehydration for its capacity to limit the exposure time of permeating CPAs, due to its ability to remove water from cells, and during rehydration to reduce osmotic stress.
Slow freezing and vitrification are the two approaches to mammalian oocyte cryopreservation.
The slow-freezing method was the first to be introduced. Slow freezing implies slow cooling rates and relatively low concentrations of CPAs in order to induce a slow dehydration to the aim of reducing chemical toxicity and osmotic shock. Slow-freezing protocols have been mainly studied by Italian researchers. Favourable success rates have been reported, with an increasing number of pregnancies recorded over the years [9] [10] [11] [12] [13] [14] [15] [16] [17] .
In recent years, vitrification has represented an attractive alternative for oocyte cryopreservation. Vitrification implies the transition of the aqueous phase into a vitreous-or glass-like state by extremely rapid cooling rates, avoiding the passage through the crystalline state and limiting ice-crystal formation [18] . Although this technique assures high oocyte viability, it involves the disadvantage of the use of very high concentrations of CPAs, which are potentially toxic. So, cells can only be exposed to cryoprotectant solutions for short periods of time [19] . Typically, vitrification procedures involve manipulations of few minutes, a time much shorter in comparison to more than 2 h required by slow-freezing methods, minimizing the time of exposure to subphysiological conditions.
Protocols have been designed to avoid ice-crystal formation and to reduce osmotic stress during freezing [8] . Solutions with reduced toxicity have been developed using, for example, a mixture of permeable CPAs and elevated concentrations of non-permeating polymers, such as sucrose [20] . Further improvements in vitrification techniques have been achieved by the adoption of multiple steps of equilibration in which oocytes are treated with progressively increasing concentrations of CPAs and then transferred to the vitrification solution [18, 21] .
Pros and cons of oocyte cryopreservation at different maturation stages
If performed inappropriately, slow cooling and vitrification may severely affect oocyte survival and physiology [22] , compromising irreversibly the ability to develop into viable embryos. In dependence of the maturation stage, oocytes have different specific physiological and biophysical properties that make them more or less sensitive to cryoinjury and CPA toxicity. In this section, such differences are comparatively discussed in relation to the oocyte cellular characteristics.
Cytoskeleton
The oocyte cytoskeleton is formed from complex fibrillar cytoplasmic structures that are necessary to maintain and modify its shape, to allow an appropriate cellular division and promote the movement of cytoplasmic organelles and membrane proteins.
Moreover, the oocyte and cumulus cell cytoskeleton play crucial roles in the process of maturation, but at the same time it is particularly sensitive to cryopreservation conditions. Understanding its dynamics is therefore fundamental to appraise the possible influences of cryostorage on oocyte quality.
In primordial or growing follicles, immature oocytes are arrested at the diplotene stage of prophase I of meiosis. They are characterized by the presence of a prominent nucleus, the germinal vesicle (GV), in which chromosomes are decondensed. Microtubules are organized in a three-dimensional network of fibres spanning across the entire cytoplasm. When the GV breaks down, the microtubular network becomes more dynamic, establishes contacts with the chromosomes, which in the meantime have condensed, and organizes into a subcortical metaphase I (MI) spindle. This structure assists the progression of chromosome segregation during the first meiotic division, enabling the extrusion of the first polar body in the perivitelline space. In the mature metaphase II (MII) oocyte, chromosomes are evenly aligned at the equatorial plate of the MII spindle. This is a dynamic structure whose microtubules undergo rapid cycles of assembly and disassembly [23] . Actin microfilaments also play an important role, providing a substrate for anchoring the meiotic spindle beneath the oocyte cortex. Likewise the extrusion of the first polar body, the subcortical localization of the MII spindle ensures a highly asymmetric second meiotic division upon penetration of the spermatozoon, limiting the loss of organelles and molecules important for embryo development.
In the mature oocyte, the most characterized cytoskeletal damage caused by cryopreservation concerns disruption of the sub-cortical actin network, microtubule depolymerization, abnormal spindle configuration and chromosome scattering [24] [25] [26] . All these effects profoundly modify the oocyte architecture and function, giving rise to cytokinesis abnormalities with subsequent developmental failure. Nevertheless, several studies demonstrate that some cytoskeletal alterations may be reversible. Under specific conditions, spindle fibres may depolymerize and repolymerize after thawing, reestablishing the physical interactions with chromosomes, which can be repositioned at the equatorial plate [27] [28] [29] [30] [31] .
In immature oocytes microtubules are not organized in the MII spindle. Therefore, in principle the cryopreservation of immature GV-stage oocytes bypasses the risk of chromosome aberrations because at this stage the chromatin is decondensed and protected by a nuclear envelope [32, 33] . However, in some cases loss of DNA integrity may be an implication of the cryopreservation of in vitro matured oocytes. Huang et al. demonstrated that there is no significant difference in postwarming survival, normal spindle morphology, chromosome alignment and incidence of aneuploidy between in-vitro and in-vivo matured murine oocytes [34] . However, they showed that oocyte IVM and vitrification cause a decrease in cleavage and blastocyst formation rates. They also suggested that this reduced developmental potential is an effect of an increment in DNA fragmentation occurring in in-vitro matured oocytes probably caused by inadequate culture conditions.
Oocyte-cumulus cell contact and interaction
Oocytes are surrounded by, and metabolically coupled with, adjacent cumulus cells. In fact, axon-like microfilament-rich projections referred to as transzonal processes [TZPs] originating from cumulus cells cross the zona pellucida and make contact with the oolemma. In the sites of contact, cumulus cells communicate with the oocyte by means of gap junctions [35] . Gap junctions appear to be critical for the transport of small size [less than 1 kDa] cumulus-derived factors, metabolites and signalling molecules that are necessary for immature oocytes to resume meiosis and acquire full cytoplasmic maturation and developmental competence [36] [37] [38] . Moreover, TZPs have a role in maintaining the GV or the meiotic spindle in the correct position in the cortex during oocyte maturation [39] [40] [41] .
A critical difference between MII-and GV-stage oocytes regards the importance of these intercellular contacts between germinal and somatic cells. While MII-stage oocytes do not rely on support from surrounding cumulus cells and therefore it is irrelevant whether cryopreservation can assure viability of the somatic compartment, cryopreservation of GV-stage oocytes requires maintenance of their communication with viable cumulus cells to preserve a mutual interaction through TZPs that is essential for the process of maturation [42] [43] [44] [45] . Firstly, it is essential to guarantee the mere cumulus cell survival after cryopreservation. It is important to optimize cryopreservation protocols considering that the large volume difference between oocyte and cumulus cells leads to diverse responses to CPAs [33] . Secondly, structural and functional integrity of TZPs is very sensitive to cryopreservation [33, 46, 47] . Cryostorage involves several conformational modifications that could severely affect physical interaction and bidirectional communication between germ and somatic cells. In particular, mechanical stress can result in oocyte-cumulus cells membrane injury and TZPs disruption [47] . Also, CPAs can cause cumulus cell disconnection during cooling, as an effect of their toxic effect on the microfilaments and microtubules cytoskeleton forming the TZPs [48] [49] [50] .
Undoubtedly, the permeability of immature oocytes to cryoprotectant agents depends not only on their membrane lipid composition [51] and cortical microfilament network [52] , but also on the presence of a somatic vestment. However, studies on this subject are not consistent. Some reports have highlighted a protective effect of cumulus cells for their ability to make CPAs penetration more gradual during cooling and protect against rapid osmotic changes during CPAs removal in thawing procedure [53] , inducing an increment in survival and fertilization rates [54] . On the other hand, other studies have suggested that cumulus cells do not have protective effects and that they interfere with the CPAs passage through ooplasm [55] . Moreover, intercellular contacts, which establish functional connections between cumulus and oocyte and facilitate communication among cumulus cells themselves, may act as potential nucleation sites that could initiate ice crystals formation between neighbouring cells [56] . However, even if cumulus cells can influence negatively the cryopreservation of GV oocytes, their presence is absolutely required for subsequent IVM. All these considerations underline the importance to maintain the integrity of TZPs during the cryopreservation of immature cumulus oocyte-complex (COCs). Cryopreservation at the immature stage is therefore an extremely problematic practice.
In a study performed on rhesus monkeys, VandeVoort et al. determined the effect of cryopreservation on GV-stage oocytes enclosed within cumulus cells either by slow or rapid cooling [50] . None of COCs cryopreserved by slow freezing using 1.5 mol/L PrOH+0.3 mol/L sucrose exhibited intact TZPs or microtubules within the ooplasm and most of the surrounding cells were shed from oocytes. Cryopreservation by rapid cooling using a mixture of DMSO, EG and sucrose caused disruption of microtubules and TZPs in almost all of COCs, but to a lesser extent than slow freezing [50] . Clearly, all these intra-and intercellular injuries caused by exposure of COCs to freezing solution can affect oocyte maturation.
Luciano et al. tested two different techniques of cryopreservation [slow freezing and vitrification] on feline immature GVstage oocytes [57] . In most cases (80 %), COCs cryopreserved by slow freezing showed a cytoskeletal distribution similar to control COCs, with microtubules distributed homogenously throughout the ooplasm and microfilaments slightly concentrated beneath the membrane. Instead, the process of vitrification provoked an increment of oocytes with an irregular distribution of cytoskeletal elements that aggregated in the cytoplasm (66.8 %). Moreover, although both cryopreservation procedures caused a decrease in gap junction coupling between the two cellular compartments, the interruption in communication was more pronounced in the vitrification group. This was reflected in an increment in the percentage of oocytes with a higher maturation capability in the slow freezing group compared to vitrified oocytes (32.5 % vs. 14.1 %). The authors explained their results hypothesizing that a controlled cooling rate in presence of CPAs during slow freezing induced a gradual efflux of water from cells minimizing the osmotic shock while the use of more concentrated solutions of CPAs required by vitrification resulted in an increment of chemical toxicity [57] . They proposed an alternative method for COC cryopreservation: the freezing of immature GV-stage oocytes devoid of cumulus cells followed by an appropriate culture system in presence of exogenous cumulus cells, which can support the resumption of meiosis, as demonstrated also in cows [58] [59] [60] . However, it is doubtful that co-cultured cumulus cells can confer full maturation ability to denuded cumulus cell-free oocytes.
Our group has investigated the cryopreservation of human COCs retrieved from IVM patients undergoing mild gonadotropin stimulation. After vitrification and warming of immature COCs, we observed massive damage of intercellular contacts (Fig. 1) . This interruption of communication between the two cellular compartments is very likely to affect oocyte maturation. Possible solutions to this problem might be: i) to adopt less traumatic protocols for dehydration and rehydration of COCs to preserve TZPs during CPA exposure; ii) to develop a system able to repair TZP structures during the subsequent in vitro culture; iii) to cryopreserve oocytes only after in vitro maturation, regardless the implication that cryopreservation can compromise the integrity of the meiotic spindle.
Oolemma
During the maturation process, oocytes undergo a change in lipid composition of their plasma membrane. It is reported that the oolemma of GV-stage oocytes contains high aquaporin [51] . In the plasma membrane of mature oocytes there are elevated concentration of saturated fatty acids (79,22 %) and a content of polyunsaturated fatty acids of 6,5 % [61] . This particular composition of lipids makes the mature oocytes membrane more fluid and so more resistant at low temperature in comparison with immature stages, decreasing their sensitivity to chilling injury [51, [62] [63] [64] .
Moreover, it has been reported a reduction in oolemmabound aquaporin content in in-vitro matured human oocytes compared to in-vivo matured controls [64] . Therefore, culture conditions may be the cause of decreased membrane permeability of CPAs and consequent increased sensitivity to cryopreservation of in-vitro matured oocytes.
During the process of cryopreservation, a drop in temperature modifies membrane properties with significant consequences for cell integrity. The major components of cellular membranes are phospholipids. The composition of these molecules, the length of fatty acid chains and their degree of unsaturation, the cholesterol level and the protein content influence membrane properties, especially fluidity. For example, low concentrations of cholesterol and polyunsaturated fatty acids increase the fluidity of membrane at low temperatures, decreasing its sensitivity to chilling injury [62, 63, 65] .
During cooling, the removal of thermal energy decreases the motility of membrane lipid bilayer. This allows the establishment of various interactions between adjacent lipid molecules. There is a temperature, called "transition temperature" (Tm), at which the membrane modifies its fluidity, passing from a liquid phase, characterized by high lateral and rotational mobility of phospholipids, to a crystal gel phase, with a reduction in mobility.
On the basis that a low lipid phase transition temperature is associated with chilling resistance [66] , Ghetler et al. investigated the difference of Tm between human zygotes, in-vitro matured and immature GV oocytes by means of a Fourier Transform Infrared spectroscopy [51] . The Tm of human zygotes is about 10°C and far below room temperature, thermal condition at which the process of dehydration takes place. This explains the resistance of zygotes to chilling injury. Instead, the Tm of unfertilized oocytes is significantly higher. In particular, the Tm of mature and immature oocytes is closer to room temperature (16.9°C and 24.4°C, respectively). This may clarify the higher sensitivity to freezing of mature and immature oocytes compared to zygotes and therefore their poor survival rates after cryopreservation by slow freezing. Similar findings have been reported in case of bovine [67] and mouse oocytes [68, 69] .
Based on the above notions, new methods may be developed to increase oocyte tolerance to cryopreservation. For example, artificial incorporation of liposomes could be adopted to modify the composition of the oolemma. A study carried out in sheep showed that a diet enrichment in polyunsaturated fatty acid produced a modification in composition and a change in physical properties of the oocyte membrane [15, 63, 70] . In particular it was demonstrated a decrease in Tm of sheep oocytes from 15°C to 4°C, a temperature much lower than room temperature, with a consequent increase in tolerance to chilling injury.
Another approach to the development of more efficient cryopreservation methods relies on the use of some substances to protect the integrity of the oocyte membrane during cooling. For example, Isachenko et al. found that the addition of egg yolk before and after freezing had a positive effect on both mouse oocytes and cumulus cells integrity [33] . This protective effect of egg yolk was more evident at higher temperatures, probably for an increase in flexibility of oocyte membrane. This effect has not yet been fully clarified, but could be explained taking into account two factors. Firstly, the egg yolk may act by coating and isolating the oocyte membrane from direct contact with cryoprotectant agents, reducing the osmotic shock caused by salt solutions to which the oocyte is subject during freezing. Secondly, some of the yolk egg components may be incorporated into the membranes reducing their predisposition to transition to a gel-like state. Such effect are thought to reduce oocyte internal damage and preserve an intact and functionally coupled cumulus complex. The problem in the possible application of this technology is that the egg yolk is a natural incompletely defined complex mixture of phospholipids and antioxidants that cannot be used in human oocyte cryopreservation. However, it remains a good starting point for future studies aimed at identifying new lipid products that can help to protect the COC during freezing.
Clinical application of immature oocyte cryopreservation
Cryopreservation of immature oocytes from stimulated cycles In human assisted reproduction, the cryopreservation of leftover immature or in vitro matured oocytes obtained from stimulated cycles has been investigated in several studies. These oocytes are known to be highly incompetent for intrinsic causes. Nevertheless, they represent a widely used model in oocyte IVM.
Recently, Wang and colleagues [71] analyzed sibling GVstage oocytes cryopreserved before [109] or after [107] in vitro maturation. Survival rate was similar between oocytes frozen before or after IVM (69.7 % vs. 70.5 %), but maturation rate was lower for oocytes cryopreserved at the GV stage (51.3 % vs. 75.7 %). Furthermore, these oocytes showed an increased rate of spontaneous activation, suggesting that it is preferable to freeze MII oocytes.
Similarly, Fasano et al. [72] showed that IVM procedure is more efficient when it is performed before oocyte vitrification. In this study, a total of 184 immature oocytes were randomly divided into two different groups: 100 were vitrified at MII-stage after IVM and 84 were immediately vitrified at GV-stage and in vitro matured after warming. Survival rate after warming was similar in both groups (86.9 % versus 84.5 %). However, oocyte maturation rate was significantly higher for oocytes matured before vitrification (46 %) than for oocytes vitrified before IVM (23.8 %). Fertilization rate and cleavage rate were similar in both groups. Approximately half of the embryos reached four cells stages in both groups, but no blastocysts were obtained. In conclusion, the study suggested that immature oocytes should be vitrified at the MII stage following IVM because oocyte maturation rates were significantly reduced when oocytes were vitrified at immature stage.
Lee et al. [73] also reported a negative influence of cryopreservation on the efficiency of maturation. In particular, the maturation rate of cryopreserved GV-stage oocytes, was lower than that of fresh controls (25 % vs. 50 %).
Tucker et al. [74] published the first birth from cryopreserved immature oocytes. They collected and cryopreserved 13 germinal vesicle oocytes after conventional ovarian stimulation in a 28-year-old woman. Oocytes were exposed to the cryoprotectants 1,2-propanediol and sucrose at room temperature before being cooled with the slow freezing technique. Three of 13 GVstage oocytes survived after warming and two of those reached the MII stage after 30 h of in vitro maturation. In vitro matured oocytes fertilized normally after ICSI and developed into cleaving embryos. The following embryo transfer resulted into a pregnancy that progressed successfully to term at 40 weeks, when a female infant was born. The experience of Tucker and colleagues is unique and no other births have been reported from GV-stage oocytes obtained from stimulated cycles.
Cryopreservation of immature oocytes obtained from IVM cycles
Cryopreservation of immature oocytes derived from IVM cycles represents an alternative fertility preservation approach for patients in whom gonadotropin stimulation is not recommended.
In recent years, some experience has been gained in this field. In 2009, Cao et al. [75] carried out a study to determine the efficacy of vitrification of human oocytes cryopreserved before and after IVM, comparing oocyte survival, maturation and fertilization rates and embryonic development after warming. The results showed no significant difference between the survival rates of the oocytes vitrified at GV-stage and those vitrified at MII stage (85.4 % vs. 86.1 %). However, oocyte maturation rates were significantly reduced when oocytes were vitrified at the GV stage (50.8 %) in comparison with the control group (70.4 %).
Further studies on oocyte vitrification after in vitro maturation have been carried out. Huang et al. [76] demonstrated that immature oocytes can be retrieved successfully from midantral follicles found in follicles of excised ovarian tissue, matured in vitro, and cryopreserved by vitrification, providing an alternative method of fertility preservation. In particular, in a small series of four patients these authors reported that the mean maturation rate following IVM was 79 % and in total eight mature oocytes were vitrified. Isachenko et al. [77] reported IVM of immature oocytes retrieved during ovarian tissue dissection in two cancer patients. Eighteen immature oocytes were recovered. Ten oocytes reached the MII stage after IVM (maturation rate: 56.3 %) and were cryopreserved using the conventional slow-freezing approach [78] .
Chian et al. reported the first live birth of a healthy baby after vitrification of in vitro matured oocytes retrieved in a natural menstrual cycle after hCG triggering [79] . In this study, 16 of 18 retrieved germinal vesicles matured in vitro with maturation rate of 88,89 %. After warming only 4 oocytes survived and three embryos were transferred, reaching a single healthy live baby.
In a previous study, Chian et al. [80] showed that vitrification of in vitro matured oocytes is less effective than vitrification of mature oocytes from ovarian stimulation treatment in terms of oocyte survival (67.5 % vs. 81.4 %) and fertilization rate (64.2 % vs. 75.6 %). However, the differences in the implantation rate per embryo (9.6 % vs. 19.1 %), clinical pregnancy rate per cycle started (20.0 %, vs. 44.7 %), and live-birth rate per cycle started (20.0 % vs. 39.5 %) were not statistically significant. They concluded that the combination of IVM treatments and oocyte vitrification could be applied to selected women to eliminate the risk associated with ovarian stimulation, such as estrogenreceptor-positive breast cancer patients.
Moreover, Imesh at al. [81] demonstrated that oocytes matured in vitro have limited developmental potential after cryopreservation and artificial activation. Sixty-three immature oocytes from seven unstimulated patients were collected from ovaries during laparoscopy, cultured in IVM medium and vitrified at the MII stage. After warming, oocytes were subjected to parthenogenetic activation and cultured for 6 days. They achieved a maturation rate of 61.9 % and a survival rate of 61.5 % after vitrification and warming. About 75 % of the surviving oocytes responded to activation. More ). These data suggest that the vitrification of GV-stage oocytes can assure high rates of survival. However, immature stage cryopreservation may involve a partial loss of the ability to mature in vitro in comparison to fresh controls, in addition to the previously described damage to the oocyte-cumulus cells intercellular communication.
Recently, we published a case report [82] that offers the proof-of-principle of the possibility to associate oocyte IVM and cryopreservation. The case involved the recovery of immature oocytes from antral follicles during a laparotomic conservative surgery for ovarian cancer. This practice did not have any additional implication for the patient because laparotomy was independently dictated by the pathology, while oocytes were obtained without previous gonadotropin stimulation. Three recovered oocytes were matured in vitro and cryopreserved by vitrification at the mature stage. Two of the three cryopreserved oocytes survived after warming. Only one fertilized normally after ICSI and 48 h post-insemination one embryo was transferred into the uterus. Even if no pregnancy was achieved, our experience demonstrates that retrieval of immature oocytes during surgery is another possibility to preserve female reproductive potential.
Conclusions
In conclusion, current evidence does not suggest an advantage in cryopreserving oocytes at the GV stage.
The original hypothesis was that the presence of the nucleus and the absence of a spindle could be an advantage for cryopreserving oocytes at GV stage because the risk of chromosome aberrations could be bypassed. Recent data have shown that other important cellular structures may be damaged. In particular, as discussed above, the damage to the cumulus cell compartment and TZPs may explain the poor performance of oocyte cryopreserved at the GV stage in terms of maturation, fertilization and embryo developmental capacity [83] [84] [85] .
Therefore, it is our opinion that cryopreservation of in vivo or in vitro matured MII-stage oocytes is a better option than cryopreservation at the GV stage.
